XXIV WORKSHOP UROLOGIA ONCOLÓGICA - III MULTIDISCIPLINARY GENITOURINARY COURSE•

17th-18th May 2019 – Hotel

Sana – Lisbon - Portugal

Scientific Program17th May

08:00             Accreditation - Secretariat

BLADDER CANCER

Chairman:                 Peter Clark - Derek Raghavan - Carlos Lopes

09:00 – 09:15         NEW PROGNOSTIC MARKERS IN BLADDER CANCER– Ferran Algaba

09:15 - 09:30         FIRST LINE IMMUNOTHERAPY – Derek Raghavan

09:30 – 09:45         MERITS OF CONVENTIONAL vs MINIMALLY INVASIVE APPROACHES –

Peter Clark

09:45 – 10:00         NEOADJUVANT THERAPY – NEXT GENERATION PROTOCOLS –

Derek Raghavan

10:00 – 10:20         BLADDER PRESERVATION BY CHEMORADIATION – Anthony Zietman

10:20 – 10:40         CLINICAL CASES – Derek Raghavan

10:40 – 11:00         DISCUSSION PANEL – Edson Pontes - Paulo Costa - Belmiro Parada

11.00 – 11:15      Coffee break

RENAL CELL CANCER

Chairman:                 Derek Raghavan - Maurizio Brausi

11:15 – 11:35         STATE OF THE ART: COMBINATION THERAPY TKI’S AND

IMMUNOTHERAPIES, NOVEL AGENTS - Cora Sternberg

11:35 – 11:50         DISCUSSION PANEL - Derek Raghavan - Maurizio Brausi

 

RENAL CELL CANCER

Chairman:                 Miguel Barbosa - José Nunes Marques- Phil Kantoff

11:50 – 12:05        PD-L1 TESTING IN RENAL CELL CARCINOMA - Pedro Oliveira                     

12:05 – 12:25         THE PLACE OF CABOZANTINIB IN METASTATIC RENAL CELL CANCER -

Isabel Fernandes

12:25 – 12:45       REAL WORLD EVIDENCE – CLINICAL CASES – Segio Vazquez

12:45 – 13:00         DISCUSSION PANEL – Francisco Botelho - Mário Fontes e Sousa - Pedro Madeira

13:10 – 14:30           Lunch

Scientific Program

17th May

PROSTATE CANCER

Chairman:                 Guilhermina Cantinho - Levin Martinez - Edson Pontes

14:30 – 14:45         FIRST LINE IN HORMONE-SENSITIVE – Phill Kantoff

14:45 – 15:00         RADIUM 223 - Helena Pena                 

15:00 – 15:15         OLIGOMETASTIC PCA DISEASE – HOW TO DEAL?  - Phill Kantoff

15:15 – 15:30         PET-PSMA – WHEN? – Levin Martinez

15:30 – 15:45         INTERMITTENT THERAPY – Maurizio Brausi

15:45 – 16:00         DISCUSSION PANEL – Jorge Oliveira - Fernando Ferrito - Fernando Manuel Calais da Silva

16:00 – 16:15      coffee-break

RENAL CELL CANCER

Chairman:                    Maurizio Brausi – Luis Costa – Emiliano Calvo

16:15 – 16:35         IMMUNOTHERAPY IN CCR – STATE OF THE ART AND FUTUR OPPORTUNITIES -

Emiliano Calvo

16.35 – 16:55         THE ROLE OF MODELING OF THE TUMOR MICROENVIRONMENT IN THE COMBINATION

OF ANTI-ANGIOGENIC AGENTS AND IMMUNOTHERAPY – Luis Costa

16:55 – 17:15         CLINICAL CASES – André Mansinho

17:15 – 17:45         DISCUSSION PANEL – Belmiro Parada - José Nunes Marques - José La Fuente Carvalho

17:45 – 18:45         POSTER EVALUATION

Scientific Program

18th May

08:00               Accreditation - Secretariat

UROTHELIAL CANCER

Chairman:                   Enrique Grande - André Mansinho - Francisco Botelho

09:00 – 09:30         ATEZOLIZUMAB  – WHAT’S NEW? – Enrique Grande

09:30 – 09:50          CLINICAL CASES – Daniela Macedo

09:50 – 10:15           DISCUSSION PANEL – Miguel Barbosa - Ricardo da Luz

 

10:15 – 10:40       coffee-break

EPIDEMIOLOGY IN GU CANCER

Chairman:                     Maurizio Brausi - Peter Clark - Rui Medeiros

10:40 – 11:05         WHAT’S NEW IN EPIDEMIOLOGY OF GENITOURINARY CANCER – Anne Lorelei Mucci

11:05 – 11:30           IMPACT OF NEW GUIDELINES FOR EARLY DETECTION, ROLE OF EMERGING

BIOMARKERS, AND ACTIVE SURVEILLANCE – Gabe Haas

11:30 – 11:50           DISCUSSION PANEL – António Araújo - Pedro Nunes

 

PROSTATE CANCER

Chairman:                Cora Sternberg - Sérgio Barroso - Bruno Pereira

11: 50– 12:10          EVOLVING LANDSCAPE IN CRPC – Cora Sternberg

12:10 – 12:30          EVOLVING LANDSCAPE IN HIGH RISK PROSTATIC CANCER – Nicolas Mottet

12:30 – 13:00           DISCUSSION PANEL – Arnaldo Figueiredo - Pedro Nunes - Sérgio Barroso

 

13:00 – 14:30           Lunch

Scientific Program

18th May

TESTICULAR CANCER

Chairman:                  José Passos Coelho – Paulo Costa – Anthony Zietman

14:30 – 14:45           RELAPSED METASTATIC NONSEMINOMATOUS GERM CELL TUMORS – Phill Kantoff

14:45 – 15:00           SEMINOMA WHEN FIRST LINE FAILS – WHAT TO DO? – Derek Raghavan

15:00 – 15:15          CLINICAL CASES – Peter Clark

15:15 – 15:45           DISCUSSION PANEL – José Passos Coelho – Edson Pontes – Augusto Pepe Cardoso

           

PROSTATE CANCER

Chairman:                     Derek Raghavan - Peter Clark– António Araújo

15:45 – 16:00           ROBOTIC SURGERY – PROS & CONS – Peter Clark

16:00– 16:15               OPEN SURGERY - PROS & CONS – Edson Pontes

16:15 – 16:30             IMUNOTHERAPY IN PCA – António Araújo

16:30 – 16:45             IS THERE A ROLE FOR RADIOTHERAPY OR PROSTATECTOMY FOR PATIENTS

WITH METASTATIC DISEASE? – Anthony Zietman

16:45 – 17:00             DISCUSSION PANEL – Paulo Costa – Nicolas Mottet - Peter Clark – Arnaldo Figueiredo

                           

 

17:00 – 18:00              POSTER EVALUATION

Faculty

MEETING ORGANIZERS

 

GPGU – Portuguese Genitourinary Group

Levine Cancer Institute / Carolinas Healthcare System

 

SCIENTIFIC BOARD

Fernando Calais da Silva – Chairman of the Portuguese genitourinary group

Derek Raghavan – President of Levine Cancer Institute, Carolinas HealthCare System

University of North Carolina School of Medicine

Maurizio Brausi – Chairman of ESOU - EAU Section of Oncological Urology

 

INTERNATIONAL FACULTY

Anne Lorelei Mucci – Harvard School of Public Health - USA

Anthony Zietman – Massachusetts General Hospital – Harvard Medical School - USA

Cora Sternberg - Weill Cornell Medicine - New York - USA

Derek Raghavan – Levine Cancer Institute – Carolinas HealthCare System – UNC School

of Medicine -  Charlotte - USA

Edson Pontes - Karmanos Cancer Center – Wayne State University School of Medicine – Detroit - USA

Emiliano Calvo – Director, Clinica STRAT – Madrid – Spain

Enrique Grande – MD Anderson – Madrid - Spain

Ferran Algaba -Fundacio Puigvert – Barcelona - Spain

Gabe Haas – Loyola University School of Medicine, Maywood– USA

Levin Martinez – Hospital Clinicas – Montevideu - Uruguai

Maurizio Brausi – San Agostino Hospedale - Modena – Italy

Nicolas Mottet – C.H.Saint Etienne - France

Pedro Oliveira – Christie Hospital – Manchester- UK

Peter Clark - Levine Cancer Institute – Carolinas HealthCare System – UNC School of Medicine –

Charlotte -  USA

Phil Kantoff – Memorial Sloan Cancer Center- USA

Sérgio Vasquez – Hospital Lucus Augusti, Lugo – Spain

Faculty

PORTUGUESE FACULTY

André Mansinho – C.H.L.N. Hospital Santa Maria - Lisboa

António Araújo – C.H.N. Hospital Santo António - Porto

Arnaldo Figueiredo – C.H.U.C. - Coimbra

Augusto Pepe Cardoso – Hospital Fernando da Fonseca - Amadora

Belmiro Parada – C.H.U.C. - Coimbra

Bruno Pereira - C.H.C.B. - Hospital da Covilhã

Carlos Lopes – ICBAS – Porto

Daniela Macedo – C.H.L.N. Hospital Santa Maria - Lisboa

Fernando Ferrito – Hospital Fernando da Fonseca - Amadora

Fernando Manuel Calais da Silva – C.H.L.C. Hospital São José - Lisboa

Francisco Botelho – C. Hospitalar São João - Porto

Guilhermina Cantinho – Atomedical - Lisboa

Helena Pena - Atomedical - Lisboa

José Carlos Nunes Marques - C.H.L.O. Hospital S.Francisco Xavier– Lisboa

José La Fuente Carvalho – C.H.N. Hospital Santo António - Porto

José Luis Passos Coelho – Hospital Beatriz Ângelo - Loures

Luis Costa – C.H.L.N. Hospital Santa Maria - Lisboa

Mário Fontes e Sousa – C.H.L.O. Hospital S.Francisco Xavier– Lisboa

Miguel Barbosa – C.H.T.M.A.D. Hospital Vila Real

Paulo Costa - Hospital Universitário - Braga

Pedro Madeira – I.P.O. - Coimbra

Pedro Nunes – C.H.U.C. - Coimbra

Ricardo da Luz – C.H.L.C. Hospital São José - Lisboa

Rui Medeiros – I.P.O. - Porto

Sérgio Barroso – Clínica de Santo António – Hospital da Luz – Amadora

POSTER JURY

Mário Reis – Prof. Agregado Jubilado– Porto

Filinto Marcelo – Clínica São Roque - Penafiel

Artur Gomes Oliveira – Clínica de Oeiras, Hospital da Luz - Oeiras

Edson Pontes - Karmanos Cancer Center – Wayne State University School of Medicine – Detroit - USA

Maria Joaquina Maurício - I.P.O. – Porto

Scientifc Meeting Organizers

E.U. Accreditation

“ The XXIV WORKSHOP UROLOGICAL ONCOLOGY - III MULTIDISCIPLINARY

GENITOURINARY COURSE, Lisbon, Portugal, 17/05/2019-18/05/2019 has been accredited

by the European Accreditation Council for Continuing Medical Education (EACCME®) with

12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours

of credit that he/she actually spent in the educational activity.”

“Through an agreement between the Union Européenne des Médecins Spécialistes and the

American Medical Association, physicians may convert EACCME® credits to an

equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to

convert EACCME® credit to AMA credit can be found at www.ama-

assn.org/education/earn-credit-participation-international-activities.”